Clinical Trials Support Services Market By Phase (Phase I, Phase II), Service (Clinical Trial Site Management, Patient Recruitment), Sponsor (Pharmaceutical Companies, Medical Device Companies), & Region for 2024-2031

Clinical Trials Support Services Market Valuation - 2024-2031

The increasing globalization of clinical trials has led to a demand for clinical trial support services that can manage trials in multiple countries and regions, propelling the market growth. The cost of developing new drugs is rising, putting pressure on pharmaceutical companies to improve efficiency and reduce costs, and surpassing USD 676.02 Million in 2024 to reach a valuation of around USD 979.93 Million by 2031.

In addition to this, technological advancements, such as electronic data capture (EDC) systems and cloud computing, are improving the efficiency and effectiveness of clinical trials. This has created opportunities for clinical trial support service providers to offer innovative solutions, enabling the niche market grow at a CAGR of 4.75% from 2024 to 2031.

Clinical Trials Support Services Market: Definition/ Overview

Clinical trial support services refer to a range of services provided to pharmaceutical and biotechnology companies to assist in the planning, execution, and management of clinical trials. These services can include activities such as site selection, patient recruitment, data management, regulatory compliance, and safety monitoring.

Clinical trial support services are essential for ensuring the efficient and successful conduct of clinical trials. They can help to reduce costs, improve data quality, and accelerate the drug development process. Clinical trial support services can be provided by specialized contract research organizations (CROs) or by in-house teams within pharmaceutical and biotechnology companies.

How the Rising Cases of Chronic Diseases Upsurging the Growth of Clinical Trials Support Services Market?

The increasing prevalence of chronic diseases worldwide has spurred pharmaceutical companies to expand their clinical trial activities globally. This trend is driving the growth of the global Clinical Trials Support Services Market, as these companies seek efficient and cost-effective ways to conduct trials across diverse populations. According to the World Health Organization, chronic diseases were responsible for 71% of global deaths in 2021, highlighting the urgent need for new treatments. For instance, on March 15, 2024, Parexel International announced the launch of its enhanced decentralized clinical trial platform, aiming to improve patient recruitment and retention rates in global studies.

The rising complexity of clinical trials, particularly in emerging therapeutic areas like gene therapy and personalized medicine, is another key driver of the market. These advanced trials require specialized expertise and sophisticated technologies, leading to increased demand for comprehensive support services. The U.S. Food and Drug Administration approved 55 novel drugs in 2023, many of which involved complex trial designs. In a significant move on September 1, 2024, IQVIA unveiled its AI-powered clinical trial optimization suite, designed to streamline protocol development and site selection processes for intricate studies.

Stringent regulatory requirements and the need for data quality and integrity are fueling the adoption of clinical trial support services. Sponsors are increasingly relying on specialized service providers to navigate the complex regulatory landscape and ensure compliance across multiple jurisdictions. The European Medicines Agency reported a 12% increase in clinical trial applications in 2023 compared to the previous year. For instance, on June 30, 2024, Syneos Health announced its acquisition of a leading regulatory affairs consultancy, bolstering its capabilities in global regulatory strategy and submission management for clinical trials.

How the Rising Patient Recruitment and Retention Restraining the Clinical Trials Support Services Market?

The global Clinical Trials Support Services Market faces significant hurdles in patient recruitment and retention. For instance, on 12 June 2024, IQVIA announced the launch of One Home for Sites(TM), a new technology platform that acts as a single sign-on and a single dashboard for the key systems and tasks a clinical research site needs to perform across all the clinical trials it is conducting. Diverse populations and stringent eligibility criteria often lead to delays and increased costs.

Regulatory compliance across different regions presents another major challenge. Varying standards and requirements necessitate careful navigation of complex regulatory landscapes. The European Medicines Agency (EMA) reported in 2022 that 68% of clinical trials conducted in the EU involved multiple member states, highlighting the need for harmonized processes. For instance, on 04 September 2024, Parexel, announced the strengthening of its Real-World Research (RWR) offering, bringing together the company's Scientific Data Organization (SDO) and Real-World Evidence (RWE) capabilities to better meet growing customer needs.

Data management and integrity pose ongoing difficulties in clinical trials. Ensuring consistent, high-quality data collection across diverse sites and systems is crucial for trial success. The U.S. Food and Drug Administration (FDA) found that data integrity issues were cited in 79% of warning letters issued to clinical trial sponsors between 2019 and 2023. To address this challenge, on 18 June 2024, Medidata launched clinical data studio, leveraging AI to modernize the data experience in clinical trials.

Category-Wise Acumens

What are the Features Bolstering the Demand of Patient Recruitment Management Segment?

Patient recruitment management has emerged as a dominant segment in the clinical trials support services market, driven by the critical need to identify, enroll, and retain suitable participants for clinical studies. This growth of this segment arises from its ability to address one of the most persistent challenges in clinical research: insufficient or slow patient enrollment. According to the National Center for Biotechnology Information (NCBI), a study published in 2022 revealed that 86% of clinical trials fail to meet recruitment timelines, underscoring the vital role of effective patient recruitment strategies.

The dominance of patient recruitment management is further reinforced by its potential to reduce costs and timelines associated with clinical trials. By employing targeted outreach, digital marketing, and data-driven approaches, service providers can significantly improve the efficiency of the recruitment process. The U.S. Department of Health and Human Services reported in 2023 that patient recruitment accounts for nearly 30% of the total time spent on clinical trials.

How will the demand for Residential Clinical Trials Support Services Impacts the Market Growth?

Pharmaceutical and biopharmaceutical companies are dominating the Clinical Trials Support Services Market due to their substantial investment in research and development, particularly for novel therapies and personalized medicines. These companies rely heavily on clinical trials to bring new drugs to market, driving demand for specialized support services. According to the U.S. National Institutes of Health (NIH), as of 2023, the pharmaceutical industry sponsored 70% of all clinical trials registered on ClinicalTrials.gov.

The complexity of modern clinical trials, especially in areas like oncology and rare diseases, has further cemented the dominance of pharmaceutical and biopharmaceutical companies in this market. These trials often require advanced technologies, specialized expertise, and global reach that many pharma companies can afford to access through support service providers. The European Medicines Agency (EMA) reported in its 2023 annual report that 62% of all clinical trial applications in the EU were submitted by pharmaceutical companies. Highlighting this trend, on 03 October 2023, IQVIA, announced a strategic collaboration with argenx to advance treatment to patients with rare autoimmune diseases through innovative and integrated technology-enabled pharmacovigilance (PV) safety services and solutions.

Country/Region-wise Acumens

How will the Developed Healthcare Infrastructure Affects the Clinical Trials Support Services Market in North America?

North America maintains a dominant position in the clinical trials support services market due to its robust healthcare infrastructure, significant R&D investments. The region's advanced technological capabilities and large pool of experienced researchers contribute to its leadership. According to the National Institutes of Health (NIH), as of 2023, the United States conducted over 40% of the world's clinical trials, highlighting its pivotal role in global drug development.

The presence of major pharmaceutical companies and contract research organizations (CROs) further solidifies North America's dominance in the market. These organizations continually invest in innovative trial designs and cutting-edge technologies to improve trial efficiency and outcomes. The U.S. Food and Drug Administration (FDA) reported that in 2022, it received 65% more Investigational New Drug (IND) applications compared to a decade ago, indicating sustained growth in clinical research activities. Addressing the increasing demand for specialized trial support, on 24 June 2021, IQVIA introduced Clinical Data Analytics Suite (CDAS), a new SaaS-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single, standardized setting for easier access and use.

How will the Strong Regulatory Framework Support the Market Growth in the Europe?

Europe is emerging as the fastest-growing region in the clinical trials support services market due to its strong regulatory framework, and increasing investment in research and development. The European Medicines Agency (EMA) reported that in 2022, the number of clinical trial applications in the EU increased by 12% compared to the previous year, indicating a growing demand for support services. This growth is further fueled by the implementation of the EU Clinical Trials Regulation, which aims to harmonize and streamline the clinical trial process across member states.

The attractiveness for clinical trials in this region is also bolstered by its diverse patient population and high-quality medical facilities. According to the European Commission's Directorate-General for Health and Food Safety, as of 2023, 19% of global clinical trials were conducted in Europe, second only to North America. This significant market share is expected to grow further as pharmaceutical companies increasingly recognize the benefits of conducting trials in the region.

Competitive Landscape

The clinical trials support services market is a dynamic and competitive landscape, with a mix of established players and emerging challengers vying for market share. These players are actively working to strengthen their presence by implementing strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are dedicated to continuously improving their product line to meet the needs of a wide range of customers in different regions.

Some of the key players operating in the clinical trials support services market include:

Charles River Laboratories International, Inc.

Wuxi Apptec, Inc

Syneos Health, Inc.

Eurofins Scientific

PPD, Inc. (Pharmaceutical Product Development)

Icon Plc

Laboratory Corporation of America Holdings (Labcorp)

Alcura

Parexel International Corporation

Latest Developments

In July 2024, DocMode Health Technologies implemented novel clinical research services. The company's objective is to offer comprehensive solutions that include data analysis, regulatory compliance, clinical trial management, and more. The service will assist pharmaceutical companies, healthcare providers, and researchers in the efficient and effective execution of high-quality clinical studies.

In June 2024, Labcorp Global Trial Connect, a central laboratory solution that was introduced, is designed to accelerate the pace of clinical trials. The solution is a digital and data solution that simplifies investigator site workflows, reduces data delays, and supports clinical trial efficacy.

Clinical Trials Support Services Market, By Category

• Phase:
• Phase I
• Phase II
• Phase III
• Phase IV
• Service:
• Clinical Trial Site Management
• Patient Recruitment Management
• Patient recruitment & Registry Services
• Patient retention
• Others
• Data Management
• Administrative Staff
• IRB
• Others
• Sponsor:
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Others
• Region:
• North America
• Asia-Pacific
• Europe
• South America
• Middle East & Africa